Category: Impact Stories

Nothing found.

Heartflow One

Platform Overview
Roadmap Analysis
FFR_CT Analysis
Plaque Analysis
Plaque Staging
PCI Navigator
Support

Why CCTA

CCTA Advantage
Clinical Evidence
Clinical Research
Reimbursement

For Patients

Understanding CAD
Why Heartflow
Patient Stories

About

About Us
Careers
Contact

Investors

Overview
News & Events
Stock Information
Corporate Governance
Financial Information
IR Resources
California Compliance Declaration

Resources

CCTA Resources
Marketing Resource Kit
Medical Education

Login

Heartflow One

Platform Overview
Roadmap Analysis
FFR_CT Analysis
Plaque Analysis
Plaque Staging
PCI Navigator
Support

Why CCTA

CCTA Advantage
Clinical Evidence
Clinical Research
Reimbursement

For Patients

Understanding CAD
Why Heartflow
Patient Stories

About

About Us
Newsroom
Careers
Contact

Resources

CCTA Resources

Investors

Overview
News & Events
Stock Information
Corporate Governance
Financial Information
IR Resources

Login

Indications
Privacy Policy
Cookie Policy
Terms of Use
Heartflow Trust Center
Modern Slavery Statement
Carbon Reduction Plan
Accessibility
Sitemap

The Heartflow Analysis, including FFR_CT Analysis, Roadmap Analysis, Plaque Analysis, and the PCI Navigator tool, is commercially available in the United States. Specific functionalities are also available in European Union, UK, Japan, Canada, and other select regions. The information provided by Heartflow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms, and other diagnostic data, as well as the clinician’s professional judgement. The Heartflow Analysis may not be appropriate for all patients. Please consult the Indications for Use and safety information for additional details.

© 2026 Heartflow, Inc. | Heartflow is a registered trademark of Heartflow, Inc. The Heartflow logo, Roadmap, PCI Navigator, Heartflow One, and Heartflow Plaque Staging are claimed trademarks of Heartflow, Inc. | www.heartflow.com | 135 Main St, San Francisco, CA 94105